Einstein in the News | Research Publications

Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore. (Wednesday, November 21, 2018)

More coverage on Dr. Steidl | Dr. Steidl's Profile


Genetic Engineering & Biotechnology News interviews Jonathan Lai, Ph.D., about new approaches to antibody engineering that could lead to novel drugs effective against various viruses, including Ebola. Dr. Lai is professor of biochemistry at Einstein. (Tuesday, August 07, 2018)

More coverage on Dr. Lai | Dr. Lai's Profile


BioTechniques features the research of Vladislav Verkhusha, Ph.D., in a story on advances in fluorescent dye and protein design for microscopy imaging. Dr. Verkhusha is professor of anatomy and structural biology. (Wednesday, December 06, 2017)

More coverage on Dr. Verkhusha | Dr. Verkhusha's Profile


Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology. (Tuesday, January 06, 2015)

Dr. Wu's Profile | Dr. Ovryn's Profile


Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics. (Tuesday, February 05, 2013)

Dr. Cowburn's Profile


MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center. (Thursday, December 13, 2012)

More coverage on Dr. Chuck | Dr. Chuck's Profile


Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics. (Wednesday, October 24, 2012)

More coverage on this story | More coverage on Dr. Emmons | Dr. Emmons' Profile


American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center. (Monday, August 27, 2012)

More coverage on Dr. Marion | Dr. Marion's Profile


The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein. (Wednesday, April 25, 2012)


New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein. (Tuesday, March 13, 2012)

More coverage on Dr. Schramm | Dr.Schramm's Profile


Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine. (Wednesday, February 01, 2012)

More coverage on Dr. Broder | Dr.Broder's Profile


Microbe features research by Liise-Anne Pirofski , M.D., about a newly identified antibody that works against pneumococcal bacteria and could help to improve vaccines against pneumonia. Dr. Pirofski is chief of the division of infectious diseases at Einstein and Montefiore Medical Center and the Selma and Dr. Jacques Mitrani Professor in Biomedical Research. (Wednesday, February 01, 2012)

More coverage on Dr. Pirofski | Dr.Pirofski's Profile

First Page | Previous Page | Page of 1 | Next Page | Last Page